Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of Multiresistant Acinetobacter baumannii
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Beginning in 1992, a sustained outbreak of multiresistant Acinetobacter baumannii infections was noted in our 1,000-bed hospital in Barcelona, Spain, resulting in considerable overuse of imipenem, to which the organisms were uniformly susceptible. In January 1997, carbapenem-resistant (CR)A. baumannii strains emerged and rapidly disseminated in the intensive care units (ICUs), prompting us to conduct a prospective investigation. It was an 18-month longitudinal intervention study aimed at the identification of the clinical and microbiological epidemiology of the outbreak and its response to a multicomponent infection control strategy. From January 1997 to June 1998, clinical samples from 153 (8%) of 1,836 consecutive ICU patients were found to contain CR A. baumannii. Isolates were verified to be A. baumannii by restriction analysis of the 16S-23S ribosomal genes and the intergenic spacer region. Molecular typing by repetitive extragenic palindromic sequence-based PCR and pulsed-field gel electrophoresis showed that the emergence of carbapenem resistance was not by the selection of resistant mutants but was by the introduction of two new epidemic clones that were different from those responsible for the endemic. Multivariate regression analysis selected those patients with previous carriage of CR A. baumannii(relative risk [RR], 35.3; 95% confidence interval [CI], 7.2 to 173.1), those patients who had previously received therapy with carbapenems (RR, 4.6; 95% CI, 1.3 to 15.6), or those who were admitted into a ward with a high density of patients infected with CR A. baumannii(RR, 1.7; 95% CI, 1.2 to 2.5) to be at a significantly greater risk for the development of clinical colonization or infection with CR A. baumannii strains. In accordance, a combined infection control strategy was designed and implemented, including the sequential closure of all ICUs for decontamination, strict compliance with cross-transmission prevention protocols, and a program that restricted the use of carbapenem. Subsequently, a sharp reduction in the incidence rates of infection or colonization with A. baumannii, whether resistant or susceptible to carbapenems, was shown, although an alarming dominance of the carbapenem-resistant clones was shown at the end of the study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 2×
“(%) of patients with CR-Ab fecal carriage prior to isolation 16 (52) 3 (5) ,0.”
BackgroundThe life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,304
A simplified acute physiology score for ICU patients
GALL, J.-R. L., LOIRAT, P., ALPEROVITCH, A., GLASER, P., GRANTHIL, C., MATHIEU, D., MERCIER, P., THOMAS, R., & VILLERS, D. (1984) · Critical Care Medicine · doi:10.1097/00003246-198411000-00012 · Cited by 1,251
[Antibiogram Committee of the French Society for Microbiology. Official Statement 1999].
Soussy, C. (1999) · PubMed · Cited by 677
Emergence of Enterococcus as a Significant Pathogen
Moellering, R. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1173 · Cited by 578
Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F., & Gaynes, R. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.211 · Cited by 436
Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop
Tomasz, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301725 · Cited by 418
Survival of Acinetobacter baumannii on dry surfaces
Wendt, C., Dietze, B., Dietz, E., & Rüden, H. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1394-1397.1997 · Cited by 400
Methicillin-Resistant Staphylococcus aureus: Introduction and Spread Within a Hospital
PEACOCK, J. E., MARSIK, F. J., & WENZEL, R. P. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-526 · Cited by 391
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features
Cisneros, J. M., Reyes, M. J., Pachon, J., Becerril, B., Caballero, F. J., Garcia Garmendia, J. L., Ortiz, C., & Cobacho, A. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.1026 · Cited by 342
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
Epstein, F. H., Jacoby, G. A., & Archer, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240906 · Cited by 312
Seifert, H., Strate, A., & Pulverer, G. (1995) · Medicine · doi:10.1097/00005792-199511000-00004 · Cited by 259
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Clinical Problems Posed by Multiresistant Nonfermenting Gram‐Negative Pathogens
Quinn, J. P. (1998) · Clinical Infectious Diseases · doi:10.1086/514912 · Cited by 213
GARCÍA, M. S., CAMBRONERO GALACHE, J. A., DIAZ, J. L., CERDÁ, E. C., BLASCO, J. R., GÓMEZ AGUINAGA, M. A., REIZ, A. N., MARÍN, S. R., OÑORO CAÑAVERAL, J. J., & SACRISTÁN del CASTILLO, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9712079 · Cited by 199
EPIDEMIC BACTEREMIA DUE TO ACINETOBACTER BAUMANNII IN FIVE INTENSIVE CARE UNITS
Beck‐Sagué, C. M., Jarvis, W. R., BROOK, J. H., Culver, D. H., POTTS, A., GAY, E., SHOTTS, B. W., Hill, B. C., Anderson, R. L., & Weinstein, M. P. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115714 · Cited by 197
Fagon, J.-Y., Chastre, J. E., Domart, Y., Trouillet, J., & Gibert, C. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.538 · Cited by 195
De Mars, G. (1989) · PubMed · Cited by 192
Getchell-White, S. I., Donowitz, L. G., & Groschel, D. H. M. (1989) · Infection Control & Hospital Epidemiology · doi:10.1086/646061 · Cited by 179
Sherertz, R. J., & Sullivan, M. L. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.2.252 · Cited by 170
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica
Musa, E. H., Desai, N., & Casewell, M. W. (1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90029-n · Cited by 106
Wolff, M., Joly‐Guillou, M., Farinotti, R., & Carbon, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1406 · Cited by 90
Silvestri, L., Monti‐Bragadin, C., Milanese, M., Gregori, D., Consales, C., & Gullo, A. (1999) · Journal of Hospital Infection · doi:10.1053/jhin.1998.0550 · Cited by 80
Vancomycin‐ResistantStaphylococcus aureus: Infection Control Considerations
Wenzel, R. P., & Edmond, M. B. (1998) · Clinical Infectious Diseases · doi:10.1086/514646 · Cited by 79
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
Brown, S., Bantar, C., Young, H.-K., & Amyes, S. G. B. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78210-6 · Cited by 64
Plasmid DNA Profiles of Acinetobacter Baumannii: Clinical Application in a Complex Endemic Setting
Seifert, H., Boullion, B., Schulze, A., & Pulverer, G. (1994) · Infection Control and Hospital Epidemiology · doi:10.2307/30148402 · Cited by 62
Jones, R. N., & Dudley, M. N. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00013-8 · Cited by 42
Joly‐Guillou, M., Decré, D., Herman, J. L., Bourdelier, E., & Bergogne-Bérézin, E. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.619 · Cited by 38
Cited by
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Maragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez-Baño, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 864
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Metadata
- Authors
- Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2000-11
- Volume
- 38
- Issue
- 11
- Pages
- 4086-4095
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2145645537
- Cited by
- 348
- References
- 40
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.